Live GMP
Aureate Tradde Ltd GMP ₹0 SMR Jewels Ltd GMP ₹0 Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹26+13.54% Merritronix Ltd GMP ₹68+45.64% Liotech Industries Ltd. GMP ₹0
Beta Drugs Ltd. Logo

Beta Drugs Ltd. IPO

Closed Fixed Price IPO NSE SME Fresh Capital
← Back to GMP
Issue Price ₹85
GMP
Lot Size 1,600
Face Value ₹10
Issue Size 2,296,000 shares (aggregating up to ₹20 Cr)
Subscription

IPO Timeline

Open Date29-Sep-17
Close Date4-Oct-17
Allotment-
Refund Initiation-
Demat Credit-
UPI Mandate Deadline4-Oct-17
Listing Date12-Oct-17

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
NII (HNI) 1,083,200 (47%) ₹921 Cr
Retail 1,083,200 (47%) ₹921 Cr
Market Maker 129,600 (6%) ₹11 Cr
Σ  Total2,296,000 (100%)₹19,516 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹85
Face Value₹10
Lot Size1,600 shares
Issue Size2,296,000 shares (aggregating up to ₹20 Cr)
Issue TypeFixed Price IPO
Listing ExchangeNSE SME
Sale TypeFresh Capital
Script Code
Net Offer to Public2,166,400 shares (aggregating up to ₹18 Cr)
Amount InRs Cr
Stock Price History · NSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)11,600₹136,000
Retail (Max)1320,800₹1,768,000
S-HNI (Min)1422,400₹1,904,000
B-HNI (Min)67107,200₹9,112,000
Retail1 lot(s)1,600 shares₹136,000
S-HNI2 lot(s)3,200 shares₹272,000

Shareholding Pattern

Pre-Issue Shareholding6,335,500 shares%
Post-Issue Shareholding8,649,500 shares%
Reserved for Market Maker129,600 shares (aggregating up to ₹1 Cr)

Valuation & Key Ratios

ROE
ROCE
RONW
PAT Margin
EBITDA Margin
Debt/Equity
P/BV
Pre EPS
Post EPS
Pre P/E
Post P/E

Grey Market Premium (GMP)

Current GMP

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • Purchase of new plant and machinery and upgradtion of the existing plant and machinery – 7.42
  • Civil Construction work at existing manufacturing unit. – 1.28
  • To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme – 0.79
  • Working Capital – 2.95
  • General Corporate Purpose – 4.10

Company Overview

Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.

Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.

Company Information

AddressVillage, Nandpur Baddi, Himachal Pradesh, 17410